CTAD 2024 | The need for digital tools to assess cognition in Alzheimer’s disease

Alexandra König, PhD, ki:elements, Saarbrücken, Germany, speaks about digital tools to assess cognition in Alzheimer’s disease, highlighting some advantages over traditional ways of measuring cognition. Dr König introduces some of the tools being investigated, including automated speech and language analysis. This interview took place at the 17th Clinical Trials on Alzheimer’s Disease (CTAD) conference in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.